Edesa Capex To Depreciation vs Days Payables Outstanding Analysis

EDSA Stock  USD 1.80  0.02  1.12%   
Edesa Biotech financial indicator trend analysis is much more than just examining Edesa Biotech latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Edesa Biotech is a good investment. Please check the relationship between Edesa Biotech Capex To Depreciation and its Days Payables Outstanding accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.

Capex To Depreciation vs Days Payables Outstanding

Capex To Depreciation vs Days Payables Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Edesa Biotech Capex To Depreciation account and Days Payables Outstanding. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Edesa Biotech's Capex To Depreciation and Days Payables Outstanding is -0.45. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Days Payables Outstanding in the same time period over historical financial statements of Edesa Biotech, assuming nothing else is changed. The correlation between historical values of Edesa Biotech's Capex To Depreciation and Days Payables Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Edesa Biotech are associated (or correlated) with its Days Payables Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Payables Outstanding has no effect on the direction of Capex To Depreciation i.e., Edesa Biotech's Capex To Depreciation and Days Payables Outstanding go up and down completely randomly.

Correlation Coefficient

-0.45
Relationship DirectionNegative 
Relationship StrengthVery Weak

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Days Payables Outstanding

Most indicators from Edesa Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edesa Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.At present, Edesa Biotech's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 1 B, whereas Selling General Administrative is forecasted to decline to about 3.6 M.
 2021 2022 2023 2024 (projected)
Cost Of Revenue118.2K183.5K165.1K156.9K
Research Development13.3M4.8M5.5M4.3M

Edesa Biotech fundamental ratios Correlations

0.230.350.75-0.8-0.590.810.41-0.020.890.230.510.10.260.970.210.320.24-0.380.190.730.44-0.140.60.450.14
0.230.8-0.29-0.29-0.270.310.00.080.280.12-0.130.460.730.27-0.10.05-0.10.570.59-0.23-0.09-0.020.02-0.18-0.28
0.350.8-0.21-0.4-0.240.430.250.20.270.260.060.520.790.31-0.330.13-0.320.260.6-0.09-0.3-0.21-0.020.09-0.11
0.75-0.29-0.21-0.34-0.570.360.440.070.580.280.59-0.05-0.440.690.320.390.35-0.56-0.480.860.56-0.240.750.660.19
-0.8-0.29-0.4-0.340.28-0.99-0.140.09-0.82-0.04-0.31-0.07-0.59-0.830.0-0.140.00.21-0.59-0.45-0.17-0.02-0.19-0.04-0.16
-0.59-0.27-0.24-0.570.28-0.32-0.49-0.47-0.53-0.47-0.01-0.450.02-0.53-0.36-0.02-0.410.110.17-0.54-0.570.32-0.93-0.380.49
0.810.310.430.36-0.99-0.320.21-0.010.810.130.320.140.590.83-0.040.15-0.04-0.170.570.470.15-0.040.230.080.15
0.410.00.250.44-0.14-0.490.210.620.050.890.550.58-0.090.21-0.360.47-0.33-0.19-0.270.39-0.15-0.810.450.640.17
-0.020.080.20.070.09-0.47-0.010.62-0.190.880.040.78-0.13-0.14-0.510.12-0.480.15-0.310.14-0.3-0.760.350.41-0.26
0.890.280.270.58-0.82-0.530.810.05-0.19-0.070.14-0.060.370.960.45-0.050.45-0.240.360.620.640.250.510.16-0.05
0.230.120.260.28-0.04-0.470.130.890.88-0.070.40.75-0.10.06-0.540.4-0.50.06-0.30.29-0.31-0.890.390.60.04
0.51-0.130.060.59-0.31-0.010.320.550.040.140.40.05-0.170.39-0.340.84-0.32-0.5-0.250.43-0.21-0.580.10.590.69
0.10.460.52-0.05-0.07-0.450.140.580.78-0.060.750.050.210.0-0.470.16-0.440.420.0-0.11-0.34-0.630.250.14-0.39
0.260.730.79-0.44-0.590.020.59-0.09-0.130.37-0.1-0.170.210.31-0.18-0.13-0.190.310.96-0.27-0.210.17-0.28-0.35-0.08
0.970.270.310.69-0.83-0.530.830.21-0.140.960.060.390.00.310.310.220.33-0.330.270.670.530.050.530.310.09
0.21-0.1-0.330.320.0-0.36-0.04-0.36-0.510.45-0.54-0.34-0.47-0.180.31-0.421.0-0.25-0.070.240.910.610.46-0.13-0.33
0.320.050.130.39-0.14-0.020.150.470.12-0.050.40.840.16-0.130.22-0.42-0.4-0.23-0.220.13-0.32-0.660.090.360.42
0.24-0.1-0.320.350.0-0.41-0.04-0.33-0.480.45-0.5-0.32-0.44-0.190.331.0-0.4-0.26-0.090.260.920.580.5-0.11-0.34
-0.380.570.26-0.560.210.11-0.17-0.190.15-0.240.06-0.50.420.31-0.33-0.25-0.23-0.260.27-0.52-0.270.14-0.21-0.47-0.46
0.190.590.6-0.48-0.590.170.57-0.27-0.310.36-0.3-0.250.00.960.27-0.07-0.22-0.090.27-0.32-0.150.35-0.37-0.5-0.04
0.73-0.23-0.090.86-0.45-0.540.470.390.140.620.290.43-0.11-0.270.670.240.130.26-0.52-0.320.49-0.150.660.710.29
0.44-0.09-0.30.56-0.17-0.570.15-0.15-0.30.64-0.31-0.21-0.34-0.210.530.91-0.320.92-0.27-0.150.490.460.670.02-0.35
-0.14-0.02-0.21-0.24-0.020.32-0.04-0.81-0.760.25-0.89-0.58-0.630.170.050.61-0.660.580.140.35-0.150.46-0.25-0.55-0.17
0.60.02-0.020.75-0.19-0.930.230.450.350.510.390.10.25-0.280.530.460.090.5-0.21-0.370.660.67-0.250.46-0.4
0.45-0.180.090.66-0.04-0.380.080.640.410.160.60.590.14-0.350.31-0.130.36-0.11-0.47-0.50.710.02-0.550.460.42
0.14-0.28-0.110.19-0.160.490.150.17-0.26-0.050.040.69-0.39-0.080.09-0.330.42-0.34-0.46-0.040.29-0.35-0.17-0.40.42
Click cells to compare fundamentals

Edesa Biotech Account Relationship Matchups

Edesa Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.8M14.6M11.6M8.9M10.2M8.7M
Other Current Liab(69.7K)1.4M(19.0K)1.7M1.6M1.7M
Total Current Liabilities1.5M1.5M2.1M1.8M2.1M1.3M
Total Stockholder Equity6.6M13.1M9.4M7.0M8.1M6.4M
Net Debt(7.0M)(7.7M)(7.1M)(5.3M)(4.7M)(5.0M)
Retained Earnings(13.1M)(26.5M)(44.0M)(52.4M)(47.2M)(44.8M)
Cash7.2M7.8M7.1M5.4M6.2M5.6M
Non Current Assets Total2.7M2.5M2.5M2.5M2.8M3.0M
Cash And Short Term Investments7.2M7.8M7.1M5.4M6.2M6.8M
Common Stock Shares Outstanding1.2M1.7M2.1M2.9M3.3M3.5M
Liabilities And Stockholders Equity10.8M14.6M11.6M8.9M10.2M8.7M
Other Current Assets802.9K1.9M745.5K448.9K516.2K402.8K
Other Stockholder Equity1.6M4.9M11.2M13.0M15.0M15.7M
Total Liab4.1M1.5M2.2M1.8M2.1M2.3M
Total Current Assets8.1M12.1M9.1M6.4M7.4M7.6M
Property Plant And Equipment Net174.8K111.6K31.2K100.1K90.1K85.6K
Net Receivables87.4K3.3M1.3M626.5K720.5K521.2K
Property Plant And Equipment Gross174.8K145.4K70.7K143.9K129.5K123.1K
Accumulated Other Comprehensive Income(287.2K)(205.3K)(213.6K)(214.6K)(246.8K)(234.5K)
Non Current Liabilities Total2.6M67.7K43.7K19.8K17.8K16.9K
Inventory224.3K(217.1K)(87.4K)(1.3M)(1.1M)(1.1M)
Common Stock18.5M34.9M42.5M46.6M53.6M39.4M
Property Plant Equipment73.1K174.8K111.6K31.2K28.0K26.6K
Accounts Payable1.5M1.4M2.1M1.7M2.0M1.2M
Net Tangible Assets5.3M4.1M10.7M7.1M8.2M4.3M
Net Invested Capital6.6M13.1M9.4M7.0M8.1M9.4M
Net Working Capital6.6M10.6M7.0M4.6M4.2M5.8M
Capital Stock18.5M34.9M42.5M46.6M53.6M38.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Edesa Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Edesa Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Edesa Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Edesa Biotech Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edesa Biotech. If investors know Edesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edesa Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.78)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.72)
Return On Equity
(1.29)
The market value of Edesa Biotech is measured differently than its book value, which is the value of Edesa that is recorded on the company's balance sheet. Investors also form their own opinion of Edesa Biotech's value that differs from its market value or its book value, called intrinsic value, which is Edesa Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edesa Biotech's market value can be influenced by many factors that don't directly affect Edesa Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edesa Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Edesa Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edesa Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.